Year To Quarter End Consolidated Statement Of Income

Chiome Bioscience Inc. - Filing #7338472

Concept 2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
129,644,000 JPY
JPY
129,644,000 JPY
JPY
129,644,000 JPY
169,404,000 JPY
JPY
JPY
169,404,000 JPY
169,404,000 JPY
Cost of sales
72,645,000 JPY
73,464,000 JPY
Gross profit (loss)
56,998,000 JPY
95,940,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
379,154,000 JPY
321,934,000 JPY
Operating profit (loss)
-189,406,000 JPY
-132,749,000 JPY
-322,155,000 JPY
-246,405,000 JPY
56,998,000 JPY
-97,697,000 JPY
-128,297,000 JPY
-193,637,000 JPY
-225,994,000 JPY
95,940,000 JPY
Non-operating income
Interest income
6,000 JPY
8,000 JPY
Non-operating income
21,008,000 JPY
428,000 JPY
Non-operating expenses
Interest expenses
568,000 JPY
337,000 JPY
Non-operating expenses
1,872,000 JPY
1,867,000 JPY
Ordinary profit (loss)
-303,019,000 JPY
-227,433,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
73,000 JPY
Extraordinary income
248,000 JPY
1,003,000 JPY
Profit (loss) before income taxes
-302,771,000 JPY
-226,430,000 JPY
Income taxes - current
1,252,000 JPY
1,252,000 JPY
Income taxes
1,252,000 JPY
1,252,000 JPY
Profit (loss)
-304,024,000 JPY
-227,683,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.